[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100626907":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":26,"locations":31,"responsibleParty":51,"collaborators":26,"id":53,"slug":26,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":54,"sex":60,"minAge":61,"maxAge":26,"enrollmentInfo":62,"targetDuration":26,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":71,"overallStatus":34,"whyStopped":26,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Casa di Cura Dott. Pederzoli","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"99mTc","ACTIVE_COMPARATOR","radioisotope technetium technique will be used for sentinel lymph node localization(99mTc)",[13],"Procedure: technetium 99 used as a tracer for sentinel lymph node",{"label":15,"type":16,"description":17,"interventionNames":18},"ICG","EXPERIMENTAL","indocyanine green fluorescent imaging technique will be used for sentinel lymph node localization (ICG)",[19],"Procedure: ICG used as a tracer for sentinel lymph node",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"PROCEDURE","ICG used as a tracer for sentinel lymph node","ICG used as a tracer for sentinel lymph node instead of technetium 99",[15],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"technetium 99 used as a tracer for sentinel lymph node","technetium 99 used as a tracer for sentinel lymph node instead of ICG",[9],[32],{"facility":33,"status":34,"city":35,"state":36,"zip":26,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Ospedale P. Pederzoli Casa di Cura Privata S.p.A.","RECRUITING","Peschiera del Garda","Verona","Italy","IT",{"type":40,"coordinates":41},"Point",[42,43],10.68614,45.43912,{"lat":43,"lon":42},[46],{"name":47,"role":48,"phone":49,"phoneExt":26,"email":50},"Francesca Guerini, MD","CONTACT","+39 0456444193","urc@ospedalepederzoli.it",{"type":52,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100626907",false,"NCT07441733","Evaluate the Implementation of Using Indocyanine Green for Sentinel Lymph Node Mapping in Breast Cancer Patients","INFLUENCE II - a Pilot Study for Implementation Identification of Sentinel Lymph Nodes in Breast Cancer Patients Through Non-invasively FLUorEsceNt Imaging Using indoCyaninE Green: a Pilot Study for Implementation","INFLUENCE II","Inclusion Criteria:\n\n* Clinically node-negative, DCIS or invasive stage T1-T3 breast cancer confirmed by biopsy\n* Preoperative axillary ultrasound to confirm clinical node-negative status\n* Indication for breast cancer surgery with SLNB via axillar incision\n* Written informed consent according to national regulations\n\nExclusion Criteria:\n\n* Patients \\\u003C 18 years old.\n* Indication for breast cancer surgery with SLNB via mastectomy incision\n* Known allergy for ICG, intravenous contrast or iodine\n* History of axillary lymph node dissection\n* Pregnancy or breast-feeding\n* Psychological, familial, sociological or geographical factors that could potentially hamper compliance with the study protocol","FEMALE","18 Years",{"count":63,"type":64},40,"ESTIMATED","INTERVENTIONAL",[67],"NA","This single-institution pilot study uses a pre- and post-implementation design to evaluate the implementation of ICG fluorescent imaging for sentinel lymph node biopsy (SLNB) in an Italian hospital.",[70],"Breast Cancer",[72,73,9,15],"breast cancer","lymph node","2026-05-06",{"date":76,"type":77},"2026-05-11","ACTUAL",{"date":79,"type":77},"2024-11-07",{"date":81,"type":64},"2026-10",{"name":5,"class":6},1]